ReviewFrontiers in public health2025
Burden of anemia in the United States from 1990 to 2019: a systematic analysis of the Global Burden of Disease Study 2019.
Review in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Anemia is a common condition that affects both male and female individuals of all ages worldwide; however, comprehensive data on the burden of anemia and its trends over time in the United States (US) are scarce. The Global Burden of Disease Study (GBD) 2019 published global age-standardized point prevalence and disability-adjusted life years (DALYs) for 204 countries and territories between 1990 and 2019. In this study, we analyzed the GBD 2019 data to explore the factors contributing to the burden of anemia in the US. Methods: In this secondary analysis of the GBD 2019 data, we extracted point estimates and 95% uncertainty intervals of DALYs to describe the health loss due to anemia in the US between 1990 and 2019. We categorized DALYs based on demographic characteristics and attributed them to anemia-causing conditions, such as dietary iron deficiency (DID), diabetes, kidney diseases, digestive diseases, and obstetric or gynecological conditions. Findings: From 1990 to 2019, anemia-related DALYs increased from 332,449 to 418,855 in the US; more than half of the DALYs were due to DID. The rates of DALYs per 100,000 people declined steadily from 1990 until the early 2000s, after which it began to increase steadily. Notably, the rates of DALYs were higher in female individuals than in male individuals for anemia due to DID, diabetes and kidney diseases, and digestive diseases up to the age of 80. There were significant variations in the health burden of anemia across different states, with the highest rates observed in Mississippi, the District of Columbia, and Alabama. Conclusion: These data on the burden of anemia-measured in years of health lost-and its upward trend over time in the US highlight the need for screening, diagnosis, and treatment of anemia to guarantee health access for all.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.